Selected Portfolio Position Review: 02-20-19

By Lance Roberts | February 19, 2019

Each week we produce a chart book of 10 of the current positions we have in our equity portfolio. Specifically, we are looking at the positions which warrant attention, or are providing an opportunity, or need to be sold.

While the portfolios are designed to have longer-term holding periods, we understand that things do not always go the way we plan. This monitoring process keeps us focused on capital preservation and long-term returns.


There are four primary components to each chart:

  • The price chart is contained within the shaded area which represents 2-standard deviations above and below the short-term moving average.  
  • The Over Bought/Over Sold indicator is in orange at the top.
  • The Support/Resistance line (green) is the longer-term moving average which also acts as a trailing stop in many cases.
  • The Buy / Sell is triggered when the green line is above the red line (Buy) or vice-versa (Sell).

When the price of a position is at the top of the deviation range, overbought and on a buy signal it is generally a good time to take profits. When that positioning is reversed it is often a good time to look to add to a winning position or looking for an opportunity to exit a losing position.

, Selected Portfolio Position Review: 02-20-19

With this basic tutorial let’s get to the sector analysis.

ABT – Abbot Laboratories

, Selected Portfolio Position Review: 02-20-19
  • ABT rallied and broke out to a new high.
  • As noted last week, the position has a “buy” signal approaching so we will use weakness to add to the position accordingly.
  • Position is extremely overbought currently
  • Stop-loss moved up to $70.

AEP – American Electric Power

, Selected Portfolio Position Review: 02-20-19
  • Like ABT, AEP has also broken out to new highs.
  • We currently only carry a 1/2 position in AEP so we will add to the position on any weakness that doesn’t violate support.
  • Currently, with a bit more than a 9% gain, we are tightening up stops.
  • Looking for opportunity to increase exposure opportunistically.
  • Stop is currently $76 Short-Term
    • Holding 1/2 position currently
    • Looking for opportunity to increase exposure opportunistically.

DOV – Dover Corp.

, Selected Portfolio Position Review: 02-20-19
  • With hopes high for a conclusion to the ongoing “trade war,” basic materials holdings have been running hot.
  • After taking profits in DOV and buying VMC, DOV has continued to rally busting out to new highs.
  • With DOV switching back onto a buy signal, we will look to add back into the position on weakness.
  • Looking for a suitable position to swap into.
  • Stops moved up to $85

CVS – CVS Health

, Selected Portfolio Position Review: 02-20-19
  • CVS has been a laggard in the portfolio and was very close to being stopped out.
  • The recent rally above short-term resistance is postive, but needs to rally above the long-term moving average to build momentum.
  • The sell-signal is improving but we are likely going to sell the position here soon when we find a suitable swap to replace it with.
  • Stops are moved up to $66

HCA – HCA Health Care

, Selected Portfolio Position Review: 02-20-19
  • HCA has rallied nicely since we added it to the portfolio.
  • With the position pushing all-time highs, and very overbought, we are going to wait for a breakout to add to our holdings.
  • Stop-loss is moved up to $135

MMM – 3M Company

, Selected Portfolio Position Review: 02-20-19
  • We initially bought MMM on the idea of a trade war resolution.
  • The recent rally has triggered a “buy” signal, but MMM is extremely overbought.
  • We initially bought 1/2 postion in MMM and are looking for an opportunity to increase exposure.
  • However, we are tightening up stops to protect our profits.
  • Stop is at $200

PEP – Pepsi Company

, Selected Portfolio Position Review: 02-20-19
  • Following a good earnings report, PEP is pushing into upper resistance and is very overbought short-term.
  • We will look to add to the position on weakness that doesn’t violate support or reverse the early “buy” signal.
  • Stop-loss moved up to $112

NSC – Norfolk Southern

, Selected Portfolio Position Review: 02-20-19
  • NSC continues to push up on all-time highs. 
  • With a buy signal trying to trigger, we will look to add to our holding on a pullback or consolidation that doesn’t violate out stop loss.
  • With NSC very overbought, a correction in the short-term is likely.
  • Stop-loss is tight at $170 currently.

UTX – United Technologies

, Selected Portfolio Position Review: 02-20-19
  • After adding UTX to our portfolio recently, the position has already gained 11%. 
  • Currently carrying 1/2 position and looking to add on a pullback to support that doesn’t violate our stop.
  • Also, UTX is extremely overbought short-term but is triggering a “buy” signal. 
  • Stop-loss moved up to $122.50

VZ – Verizon

, Selected Portfolio Position Review: 02-20-19
  • Like CVS, VZ has been a portfolio laggard. 
  • Currently, with VZ on a “sell” signal, we are tightening up stops and will look to potentially swap the position into a stronger performer when we find the right opportunity.
  • VZ is working off its overbought condition currently. 
  • Stop-loss is moved up to $64

Talk with an Advisor & Planner Today!


Lance Roberts is a Chief Portfolio Strategist/Economist for RIA Advisors. He is also the host of “The Lance Roberts Podcast” and Chief Editor of the “Real Investment Advice” website and author of “Real Investment Daily” blog and “Real Investment Report“. Follow Lance on Facebook, Twitter, Linked-In and YouTube
Customer Relationship Summary (Form CRS)

> Back to All Posts